Top Markets
Coin of the day
VIA Pharmaceuticals, Inc. VIA Pharmaceuticals, Inc.

VIA Pharmaceuticals, Inc.

VIAP
Hisse Senetlerindeki Sıralama #41780
VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily... VIA Pharmaceuticals, Inc. is an emerging biotechnology company primarily focused on discovering and advancing therapeutic compounds for cardiovascular and metabolic disorders. The firm is building a portfolio of small-molecule drug candidates designed to tackle the root causes of these health issues, such as vascular inflammation, elevated cholesterol and triglyceride levels, and insulin resistance or diabetes. Notable candidates in their development pipeline include: VIA-3196: A liver-specific thyroid hormone receptor (THR) beta agonist, poised for Phase 1 clinical studies. This drug aims to mitigate dyslipidemia, addressing high LDL cholesterol, elevated triglycerides, and Lp(a) levels. A Diacylglycerol Acyl Transferase 1 (DGAT1) inhibitor: Currently in preclinical development for treating type 2 diabetes, with promising potential for weight management and other lipid disorders. VIA-2291: A 5-Lipoxygenase inhibitor that has successfully completed its third Phase 2 clinical trial. Its purpose is to target atherosclerotic plaque, a significant contributor to heart attacks, strokes, and various other vascular diseases. VIA Pharmaceuticals has also forged two research, development, and commercialization agreements with Hoffman-LaRoche Inc. and Hoffman-LaRoche Ltd. These collaborations pertain to their THR beta agonist program and several compounds from their preclinical DGAT1 metabolic disorders initiative. Established in 2004, the company's headquarters are located in San Francisco, California.
Hisse Fiyatı
$0.0005
Son senkronizasyon: 2026-08-11
Piyasa Değeri
$10.28K
Değişim (1 gün)
0.00%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret VIA Pharmaceuticals, Inc. (VIAP)

Kategori

VIA Pharmaceuticals, Inc. (VIAP) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.00 - 2026-08-01

Gün sonu en düşük fiyat: $5.07 - 2007-06-01
VIA Pharmaceuticals, Inc. için hisse fiyatı geçmişi: 2007 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 0.00%
2025 10.50%
2024 45,147.62%
2023 0.00%
2022 0.00%
2021 -99.97%
2020 10.50%
2019 6.53%
2018 -48.67%
2017 89.41%
2016 -30.00%
2015 -73.45%
2014 11.70%
2013 -20.93%
2012 118.55%
2011 -85.81%
2010 -81.24%
2009 64.56%
2008 -92.98%
2007 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$59.08 62.03%
US
$49.64 72.06%
SE
$183.02 42.25%
FR
$62.63 5.31%
IT
$113.04 55.27%
US